S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
NASDAQ:HSCS

Heart Test Laboratories (HSCS) Stock Price, News & Analysis

$0.12
0.00 (0.00%)
(As of 03/28/2024 ET)
Today's Range
$0.11
$0.12
50-Day Range
$0.12
$0.18
52-Week Range
$0.11
$1.49
Volume
1.46 million shs
Average Volume
2.86 million shs
Market Capitalization
$7.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HSCS stock logo

About Heart Test Laboratories Stock (NASDAQ:HSCS)

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

HSCS Stock Price History

HSCS Stock News Headlines

the most reliable asset on earth is making a comeback
Global tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.
Recap: Heart Test Laboratories Q3 Earnings
Heart Test Laboratories Inc
A lot of people are making this costly mistake
You may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time.
Best At-Home Blood Tests: A 2024 Guide
HeartSciences Expands its Scientific Advisory Board
See More Headlines
Receive HSCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Heart Test Laboratories and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/14/2023
Today
3/28/2024
Fiscal Year End
4/30/2024
Next Earnings (Estimated)
7/16/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
NASDAQ:HSCS
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Net Income
$-6,350,000.00
Pretax Margin
-33,636.84%

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.13 per share

Miscellaneous

Free Float
63,779,000
Market Cap
$7.66 million
Optionable
Not Optionable
Beta
3.44
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

HSCS Stock Analysis - Frequently Asked Questions

How have HSCS shares performed in 2024?

Heart Test Laboratories' stock was trading at $0.1710 at the start of the year. Since then, HSCS shares have decreased by 31.6% and is now trading at $0.1169.
View the best growth stocks for 2024 here
.

Are investors shorting Heart Test Laboratories?

Heart Test Laboratories saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 506,000 shares, an increase of 157.9% from the February 29th total of 196,200 shares. Based on an average daily trading volume, of 2,900,000 shares, the days-to-cover ratio is presently 0.2 days. Currently, 1.0% of the shares of the company are sold short.
View Heart Test Laboratories' Short Interest
.

When is Heart Test Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 16th 2024.
View our HSCS earnings forecast
.

How were Heart Test Laboratories' earnings last quarter?

Heart Test Laboratories, Inc. (NASDAQ:HSCS) posted its quarterly earnings results on Thursday, December, 14th. The company reported ($0.16) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by $0.04.

When did Heart Test Laboratories IPO?

Heart Test Laboratories (HSCS) raised $9 million in an initial public offering (IPO) on Wednesday, June 15th 2022. The company issued 1,800,000 shares at a price of $4.50-$5.50 per share. The Benchmark Company served as the underwriter for the IPO.

Who are Heart Test Laboratories' major shareholders?

Heart Test Laboratories' stock is owned by a variety of institutional and retail investors. Top institutional investors include Virtu Financial LLC (0.40%), Vanguard Group Inc. (0.28%) and Vanguard Group Inc. (0.28%).

How do I buy shares of Heart Test Laboratories?

Shares of HSCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HSCS) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners